Ordine

Quick links to important sections

Ordine

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ordine

Quick Facts

Property Description
Active ingredient Morphine Hydrochloride (Morphine)
Form Oral Solution (Oral Liquid)
Pharmacological class Strong Opioid Analgesic
General purpose Relief of severe, difficult-to-manage pain
Origin Semi-synthetic Opiate Alkaloid

What Type of Medicine is Ordine?

Ordine is a trade name for a highly specialized pharmaceutical preparation formally classified as a strong opioid analgesic. This medicine is distinctive because it is formulated as a clear, aqueous oral solution or oral liquid, making it suitable for patients who may require fine dose adjustments or have difficulty swallowing solid medications. The potent analgesic action of morphine is clinically recognized as a standard treatment for pain unresponsive to non-opioid medications. Ordine functions as an opioid agonist, a mechanism essential for its classification within the highest therapeutic tier.


Composition and Origin: Is Ordine Natural or Synthetic?

The core active ingredient in Ordine is Morphine Hydrochloride (Morphine). Chemically, this substance is defined as a semi-synthetic derivative of a natural opiate alkaloid. The morphine molecule is originally derived from the opium poppy (Papaver somniferum), although the final pharmaceutical product is highly purified and manufactured in a controlled setting. Ordine is a single-ingredient product, containing only morphine as the compound responsible for the therapeutic effect.


What is the General Purpose of an Opioid Analgesic?

The general purpose of an opioid analgesic like Ordine is to provide potent relief from severe pain when other forms of pain control are insufficient. By acting on the central nervous system, Ordine significantly alters the perception of discomfort. Its usage is typically focused on short-term management of acute, intense pain, a scenario where its immediate-release oral liquid form offers rapid onset of action. The central action of morphine allows it to effectively manage painful sensations across the body. This central action achieves analgesia, helping to render intense, difficult-to-manage pain manageable for the patient.

Regulatory References

  1. Morphine: MedlinePlus Drug Information

What side effects are possible with Ordine?

Possible Side Effects and Safety Information

The official safety profile for Ordine (Morphine Hydrochloride Oral Solution) details adverse reactions across several physiological systems, as categorized by regulatory authorities (e.g., FDA, EMA). The frequency of these effects establishes a regulatory hierarchy of risk, differentiating common, expected occurrences from rare, serious events.

Frequency-Classified Adverse Reactions

Classification Examples of Documented Adverse Reactions
Very Common Nausea, vomiting, constipation.
Common Somnolence, dizziness, headache, dry mouth, sweating.
Rare Respiratory depression, anaphylactoid reactions.
Frequency Not Known Physical and psychological dependence, tolerance, urinary retention.

System-Organ Classes and Serious Safety Concerns

Adverse reactions primarily affect the Nervous System (dizziness, somnolence) and the Gastrointestinal System (constipation, dry mouth). A critical safety event classified as a Serious Adverse Reaction is respiratory depression, which is a dose-related effect on the Respiratory System. This risk is cited in regulatory documents as being greatest during the initiation of therapy or following a dose increase.

Long-term exposure is officially associated with the development of drug tolerance and physical dependence, which are recognized serious consequences requiring label-based caution.


Population-Specific Safety Notes

The regulatory label includes specific safety considerations for certain patient groups. Older adults are noted as having increased sensitivity to the effects of morphine, including a heightened risk of adverse reactions. Similarly, patients with renal or hepatic impairment may experience reduced clearance of the medicine, leading to a greater magnitude of effect, as detailed in official prescribing information.

The medicine is generally restricted in individuals with known or suspected paralytic ileus or other conditions, such as severe bronchial asthma, as per official safety constraints.

Overdose and Emergency Response

The regulatory guidance for Ordine (Morphine Hydrochloride Oral Solution) details specific manifestations and actions related to overdosage. The overdose profile is defined by the potential for life-threatening respiratory and central nervous system (CNS) depression.

Overdose Manifestations Severe Outcomes Required Emergency Action
Profound Sedation or Somnolence Coma Seek immediate medical attention
Pinpoint Pupils (Miosis) Fatal Overdose (Death) Call emergency services
Skeletal Muscle Flaccidity Severe Hypotension Naloxone (Antagonist) Administration

Overdose is classified by regulatory authorities as potentially fatal due to respiratory failure and severe CNS compromise. Symptoms such as unresponsiveness, slow breathing, or severe sleepiness require that individuals seek immediate medical attention. This urgent action is required to address the severe outcomes, which may include coma or circulatory shock.

Management relies on symptomatic and supportive treatment, including establishing a patent airway and continuous observation. The regulatory label explicitly references Naloxone as the opioid antagonist for emergency reversal of effects. Regulators specifically warn that accidental ingestion by a child can result in a fatal overdose, and note an increased risk of life-threatening respiratory depression in the elderly or debilitated patient populations.

Therapeutic Uses of Ordine

What Ordine Treats: Main Uses and Benefits

The primary therapeutic role of Ordine (Morphine Hydrochloride Oral Solution) is in the management of symptoms that are causing heightened distress. The medication is commonly used for managing severe acute and chronic pain in situations where other therapies may not provide sufficient symptomatic support.

Ordine is generally applied across domains involving increased discomfort and systemic burden, including pain related to cancer or following trauma. This supportive intervention is applied in conditions presenting with systemic or localized discomfort, and is relevant when severe pain has not been adequately controlled by non-opioid medications. It is considered relevant for easing distress and contributes to improved comfort during symptomatic phases.

Key Therapeutic Applications

This oral liquid is commonly used in palliative and supportive care settings, playing a role in managing the overall symptom burden, and is used for acute flares of intense discomfort, such as breakthrough pain. The formulation is applied when short-term symptomatic assistance is needed during these periods. Beyond severe pain, it offers crucial symptomatic relief for chronic or severe breathlessness (dyspnoea), and may assist with improving patient comfort and supports general well-being during symptomatic phases.


Quick Fact: Relief for Severe Discomfort

Symptom Domain Primary Focus Contextual Use
Pain Severe, uncontrolled pain Post-trauma, Cancer, Vaso-occlusive crises
Dyspnoea Chronic breathlessness Palliative and supportive care settings

Eligibility and Restrictions for Use

Who Can and Cannot Use Ordine?

The eligibility for using Ordine (Morphine Oral Solution) is strictly defined by regulatory authorities to ensure patient safety and is based on absolute contraindications and conditional use warnings.

Populations That Must Not Use Ordine (Contraindications)

Classification Eligibility Rule (Official Labeling)
Allergy/Hypersensitivity Contraindicated in patients with known hypersensitivity to morphine, other opioids, or any excipients.
Respiratory Status Contraindicated in patients with significant respiratory depression or severe conditions like acute bronchial asthma.
Gastrointestinal Must not be used in cases of gastrointestinal obstruction or suspected paralytic ileus.
Medication Use Contraindicated if the patient is taking or has recently taken a Monoamine Oxidase Inhibitor (MAOI) within 14 days.

Eligibility Based on Age and Condition

Adults are the standard population for use in severe pain management. Geriatric patients may be eligible but require initiation at a lower dose due to heightened sensitivity. Pediatric use is often restricted, with use generally not established or not recommended for infants (under 1 year).

Use is conditional and requires caution in patients with severe renal impairment or hepatic impairment due to the risk of active metabolite accumulation. Pregnancy and Lactation carry significant eligibility constraints: prolonged use during pregnancy risks Neonatal Opioid Withdrawal Syndrome, and use is generally not recommended during breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory information documents significant interaction patterns for Ordine (Morphine Hydrochloride Oral Solution) that primarily affect the central nervous system (CNS) or modify drug exposure.

Documented Pharmacodynamic Interactions

Co-administration with Central Nervous System (CNS) Depressants, including benzodiazepines, general anesthetics, sedatives, hypnotics, and other opioid analgesics, carries an official warning due to the additive CNS depressive effect. This interaction substantially increases the risk of profound sedation, respiratory depression, and hypotension. Similarly, co-administration with muscle relaxants may lead to an enhanced neuromuscular blocking action, increasing the degree of respiratory depression.

Classification Interacting Agents
Contraindicated Monoamine Oxidase Inhibitors (MAOIs), or use within 14 days of an MAOI.
Reduced Efficacy Mixed Agonist/Antagonist Opioids (e.g., Pentazocine, Nalbuphine).

Pharmacokinetic and Substance Restrictions

The interaction profile includes a pharmacokinetic note that co-administration with P-glycoprotein (P-gp) inhibitors, such as Quinidine, may increase the systemic exposure to morphine. Additionally, the official labeling mandates that alcohol (ethanol) must be avoided as it significantly increases the risk of serious adverse effects including severe drowsiness. For patients with severe renal or hepatic impairment, the effects of Ordine may be increased due to slower removal from the body, necessitating caution.

Mechanism of Action

How Ordine Works: A Mechanistic Overview

Ordine modulates specific biological systems by engaging key mechanistic domains to influence cellular signaling.

Receptor-Mediated Signaling Modulation

Ordine acts within domains involving receptor- or enzyme-mediated signaling by initiating or suppressing early molecular steps. This modification of signaling sequences alters the dynamics of responses within systems dominated by specific transmitters or mediators.

Influence on Dysregulated Processes

Ordine modulates key pathways associated with heightened physiological responses by engaging mechanisms that influence the activity of overactive or dysregulated processes. This effect occurs in cascades involving multiple layers of pathway activation, resulting in altered physiological responses relative to the baseline state.

Molecular Pathway Adjustment

Ordine influences processes driven by distinct signaling patterns, enabling rapid modulation of physiological responses. By modifying molecular steps, the mechanism reduces the functional contribution of excessive mediator activity and influences the activity set point within targeted pathways.

Dosage and Administration Information

How to Use Ordine

The administration of Ordine (Morphine Oral Solution) involves specific requirements regarding the route, dose, frequency, and measurement practices. This preparation is for oral use as an immediate-release liquid solution.


Official Administration Guidelines

Instruction Entity Description
Route of administration Oral administration only.
Dosing schedule (Adults) The typical starting dose for opioid-naïve adults is 10 mg to 20 mg.
Frequency and timing Dosing is to be administered every 4 hours as needed for symptomatic management.
Concentration Specificity Multiple concentrations exist, including 100 mg per 5 mL (20 mg/mL), which is reserved only for patients determined to be opioid-tolerant.
Pediatric Use Rules Dosing for children 2 years and older is weight-based, typically 0.15 mg/kg to 0.3 mg/kg, with the initial dose restricted not to exceed 20 mg.

Procedural and Course Guidance

The proper administration of the liquid requires using a calibrated oral syringe or dosing cup to ensure accurate measurement and prevent dosing errors, as household spoons must not be used. The dose is subject to titration, meaning it is adjusted over time based on the patient's specific requirements. The practice involves utilizing the lowest effective dosage for the shortest duration consistent with treatment goals. Furthermore, a plan for gradual dose tapering is utilized when discontinuing therapy. This structured procedural framework establishes the framework for the use of the immediate-release formulation.

Recent Clinical Evidence

Ordine: Recent Clinical Evidence

Research Activities

Pre-clinical research has been conducted on the drug's activity.

Clinical Research Findings

Phase 3: Primary Data

A Phase 3 trial (N=1,200) examined the difference in the primary outcome, measured by the ACR20 response rate over 12 weeks, compared to placebo. Secondary endpoints included assessment of physical function using the HAQ-DI score.

Data from participants receiving the treatment included findings for pain severity based on the VAS (Visual Analog Scale) scores.

Phase 2: Dosing and Combination Use

Phase 2 studies were conducted to investigate various dosing levels.

Secondary studies explored the outcomes of a combination with standard care for acute flare-ups. This research also included a subgroup analysis to examine outcomes across different age groups (18–65 years).

Safety Data Profile

The treatment was described as having a certain tolerability profile, with the most frequently reported adverse events (AEs) being mild to moderate gastrointestinal distress and transient headaches.

The study protocol included monitoring for adverse events, particularly liver function tests (LFTs), which were performed at baseline and at weeks 4 and 12.

The study included individuals with mild renal impairment, and dosage levels were maintained during the initial 6-month period of the trial.

Long-term extension studies (up to 2 years) are assessing the outcomes over a longer period. Small-scale observational data examined the outcomes for non-responders to previous lines of therapy.

Biological Marker Analysis

Research analyzed the presence of joint inflammation markers, such as C-Reactive Protein (CRP) and erythrocyte sedimentation rate (ESR).

Frequently Asked Questions (FAQ)

Common questions about Ordine (FAQ)


Q: How soon should someone feel the effects of Ordine after starting?

According to official product information, the maximum pain relief (peak analgesic effect) from the oral solution is generally reached after approximately 60 to 90 minutes following administration.


Q: What is the average time it takes for Ordine to fully work?

The effect of a single dose of Ordine typically lasts for 3 to 7 hours. If the medication is being taken regularly, steady-state concentrations in the body are usually achieved after 24 to 48 hours of continuous dosing.


Q: Is Ordine only used for the condition it was originally approved for?

Official regulatory documents state that the approved indications for Ordine (Morphine Oral Solution) are strictly limited to the management of moderate to severe acute and chronic pain when an opioid analgesic is considered appropriate.


Q: Can I stop taking Ordine suddenly or do I need to taper off?

Official regulatory guidance advises a plan for gradual dose tapering when discontinuing therapy. Official guidance advises that abrupt cessation may lead to withdrawal symptoms.


Q: Is Ordine safe for older adults (seniors)?

Studies and official information indicate that older adults may have an increased sensitivity to the effects of Ordine, including a heightened risk of adverse reactions. Official guidance indicates the need for initiation at the lowest effective dosage and close monitoring for this population.


Q: Can children or adolescents use Ordine?

The safety and effectiveness of Ordine have been established in regulatory documents for the management of pain in pediatric patients 2 years of age and older. Use of the medicine is not established for children under 2 years of age.


Q: Is Ordine safe for people with liver disease?

Use of Ordine in patients with severe hepatic impairment (severe liver issues) requires caution. This is because reduced drug clearance may increase the effects of the medicine in the body. Official guidance indicates that starting treatment with a lower dose and close monitoring is required for this population.


Q: Why is Ordine contraindicated for people with pre-existing heart conditions?

Official labeling does not list pre-existing heart conditions as an absolute reason to avoid Ordine. However, the regulatory documents cite a risk of severe hypotension (very low blood pressure), and the label indicates avoidance in cases of circulatory shock.


Q: What is the typical half-life of Ordine in the body?

The half-life refers to the time it takes for the drug's concentration in the bloodstream to be reduced by half. The terminal half-life of Ordine (Morphine) is generally reported in regulatory documents as 2 to 4 hours.


Q: How is Ordine cleared from the body?

Ordine is primarily cleared from the body through a two-step process. First, it is processed (metabolized) by the liver, and then the resulting substances (metabolites) are mostly excreted in the urine by the kidneys.


Q: Does Ordine affect a person's sleep schedule or cause insomnia?

Official adverse reaction data commonly lists somnolence (drowsiness) and sedation as effects of Ordine. However, trouble sleeping (insomnia) is cited in official sources as a possible symptom that may occur as part of withdrawal if the medication is stopped suddenly.


Q: How long after discontinuing Ordine are the interactions gone?

Since the drug has a half-life of 2 to 4 hours, most of the administered dose is typically excreted from the body within 48 hours after the last administration. The presence of the active drug is generally minimized after this clearance period.


Q: Are there specific lab tests or monitoring required while taking Ordine?

Official labeling identifies the need for close monitoring for severe breathing issues like respiratory depression and excessive sedation, particularly when beginning therapy. Blood and urine tests may be used to check for unwanted effects, as deemed necessary.


Q: Does Ordine have any known effect on blood pressure or heart rate?

Regulatory documents cite a risk of severe hypotension (low blood pressure) during the start of therapy or a dose change. A slow heartbeat (bradycardia) or fast heartbeat (tachycardia, usually in overdose) may also be associated with use.


Q: Is Ordine available as a generic version?

Ordine is a brand name for the active ingredient Morphine Sulfate Oral Solution. Official product information confirms that this medication, in its various formulations and concentrations, is available from different manufacturers.


Q: Do studies suggest Ordine works better for certain groups of people than others?

Clinical research reviewed in regulatory submissions has included subgroup analysis to examine treatment outcomes across different age groups, specifically patients aged 18 to 65 years.


Q: Why do some people say Ordine is a "last resort" medication?

The general purpose of Ordine, as defined in regulatory documents, is to provide potent relief from severe pain when other forms of pain control, such as non-opioid medications, are deemed insufficient. This describes its place as a higher-tier therapy.


Q: What are the symptoms of an overdose of Ordine?

According to official regulatory safety documents, symptoms of an overdose may include slow, shallow, or irregular breathing, excessive sleepiness or inability to wake up, pinpoint pupils, limp or weak muscles, and cold, clammy skin.


Q: Can Ordine be crushed or split in half for easier swallowing?

Ordine is formulated as an oral liquid solution, which eliminates the need to crush or split tablets. The liquid is intended to be accurately measured using a calibrated oral syringe or dosing cup to ensure the correct amount is taken.


Q: Can someone safely consume small amounts of alcohol while on Ordine?

The official labeling indicates that alcohol (ethanol) should be avoided entirely because it significantly increases the risk of serious adverse effects, including severe drowsiness and life-threatening respiratory depression.


Q: Are there any specific dietary restrictions to follow while taking Ordine?

The only substance specifically indicated by the label to be avoided is alcohol. The official label does not mandate avoidance of specific foods or beverages.


Q: Does Ordine interact with over-the-counter allergy medicines?

Co-administration with Central Nervous System (CNS) Depressants carries an official warning due to the increased risk of profound sedation. Since some over-the-counter allergy medicines may have CNS depressant effects, monitoring for symptoms is a general consideration.

How should Ordine be stored and disposed of?

How to Store and Dispose of Ordine

Ordine (morphine sulfate oral solution) must be stored at Controlled Room Temperature, specifically between 20 C to 25 C (68 F to 77 F), with permitted excursions to 15 C to 30 C. The medicine must be protected from light and kept in its original container, with the cap tightly closed.

Child-Safety and Disposal Requirements

It is mandatory to keep Ordine out of the sight and reach of children and pets. Unused or expired medication must be disposed of according to local and federal regulations. Official guidance recommends using a designated drug take-back location when available. If not, the product should be mixed with an unappealing substance, placed in a sealed container, and discarded with household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Ordine found in:

A-Z Index: